-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
January 30, 2020 - RCT, cluster RCT, clinical trial, cohort study, case-control study),
number of participants (study size
-
hcup-us.ahrq.gov/reports/statbriefs/sb245-Substance-Inpatient-Stays-Across-US-Counties.pdf
February 01, 2018 - The vast size of the
NIS allows the study of topics at the national and regional levels for specific
-
hcup-us.ahrq.gov/reports/methods/2008_07.pdf
January 01, 2008 - • Urban Influence Codes (UIC) – classifies U.S. counties by size of the largest city
and nearness
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/cHbBWNok76hRWKDXXm3R2_
February 13, 2018 - ; any solid area
or papillary projection
extending into the cavity
of a cystic ovarian tumor
of any size
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/chronic-obstructive-pulmonary-disease-screening-2016
April 05, 2016 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Evidence Summary
Chronic Obstructive Pulmonary Disease: Screening
April 05, 2016
Recommendations made by the USPSTF are independent of the U.S. government. They sh…
-
www.ahrq.gov/sites/default/files/publications/files/prioritization-report_0.pdf
January 01, 2020 - Inventory and Prioritization of Measures To Support the Growing Effort in Transparency Using All-Payer Claims Databases
Final Contract Report
Inventory and Prioritization of Measures To
Support the Growing Effort in Transparency
Using All-Payer Claims Databases
Prepared for:
Agency for Healthcare Research and …
-
cdsic.ahrq.gov/sites/default/files/2024-10/IAS_Key%20Factors%20and%20Considerations%20for%20Assessing%20the%20Value%20of%20PC%20CDS.pdf
January 01, 2024 - Implementation, Adoption, and Scaling Workgroup: Key Factors and Considerations for Assessing the Value of Patient-Centered Clinical Decision Support
Implementation, Adoption, and
Scaling Workgroup: Key Factors
and Considerations for Assessing
the Value of Patient-Centered
Clinical Decision Support
…
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/measure_retirement/supplemental-materials/supplementaldoc3.pdf
September 01, 2014 - Criterion Comment on Measure 18 : ADHD Follow-Up Care (6y-12y)
�
Excellent PI opportunity given size
-
cdsic.ahrq.gov/sites/default/files/2024-09/Quartz%20Assessment%20Report_Public%20Version_0.pdf
January 01, 2024 - Using Theory to Explore the Determinants of Medication Adherence; Moving
Away from a One-Size-Fits-All
-
www.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/medical-office/Medical-Office-Users-Guide-2021.pdf
January 01, 2021 - Size
We recommend administering the survey in medical offices with at least five providers and
staff
-
www.ahrq.gov/sites/default/files/wysiwyg/cpi/about/organization/nac/snac-executive-summary.pdf
October 19, 2021 - AHRQ Subcommittee of the National Advisory Council on Healthcare Quality Measurement: Executive Summary
AHRQ SUBCOMMITTEE OF THE NATIONAL ADVISORY COUNCIL
ON HEALTHCARE QUALITY MEASUREMENT
EXECUTIVE SUMMARY
- 1 -
…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-196-disposition-comments-immunotherapy-asthma.pdf
March 23, 2018 - Effect size alone does not determine the
ability to draw conclusions.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-2007_executive.pdf
January 01, 2007 - Layout 1
Background
Depressive disorders such as major
depressive disorder (MDD), dysthymia,
and subsyndromal depression (including
minor depression) may be serious disabling
illnesses. MDD is the most prevalent,
affecting more than 16 percent (lifetime) of
U.S. adults. In 2000, the U.S. economic
burden of depressiv…
-
digital.ahrq.gov/sites/default/files/docs/page/C_RelevantLegalRequirementsforHealthDataExchange_1.pdf
May 23, 2007 - are selected based on a “flexible approach,” under which Covered Entities take
into account their size
-
digital.ahrq.gov/sites/default/files/docs/page/C_RelevantLegalRequirementsforHealthDataExchange_0.pdf
May 23, 2007 - are selected based on a “flexible approach,” under which Covered Entities take
into account their size
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary48/suicide-risk-screening-2004
May 15, 2004 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Evidence Summary
Suicide Risk: Screening
May 15, 2004
Recommendations made by the USPSTF are independent of the U.S. government. They should not be const…
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/tfannrpt2011.pdf
January 01, 2012 - First Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services
First Annual Report to Congress on
High-Priority Evidence Gaps for
Clinical Preventive Services
October 2011
Submitted by:
Dr. Virginia Moyer, Chair
Dr. Michael LeFevre, Vice Chair
Dr. Albert Siu, Vice Chair
On beh…
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening
June 24, 2025 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Evidence Summary
Intimate Partner Violence and Caregiver Abuse of Older or Vulnerable Adults: Screening
June 24, 2025
Recommendations made by the USPSTF are independent of…
-
digital.ahrq.gov/sites/default/files/IAS_Key%20Factors%20and%20Considerations%20for%20Assessing%20the%20Value%20of%20PC%20CDS.pdf
October 01, 2024 - Implementation, Adoption, and Scaling Workgroup: Key Factors and Considerations for Assessing the Value of Patient-Centered Clinical Decision Support
Implementation, Adoption, and
Scaling Workgroup: Key Factors
and Considerations for Assessing
the Value of Patient-Centered
Clinical Decision Support
…
-
digital.ahrq.gov/sites/default/files/Quartz%20Assessment%20Report_Public%20Version_0.pdf
August 05, 2024 - Using Theory to Explore the Determinants of Medication Adherence; Moving
Away from a One-Size-Fits-All